References
Bourassa MG, Gurne O, Bangdiwala SI, et al. Natural history and patterns of current practice in heart failure. J Am Coll Cardiol 1993; 22:14A–19A.
Tillisch J, Brunken R, Marshall R, et al. Reversibility of cardiac wall motion abnormalities predicted by positron tomography. N Engl J Med 1986; 314:884–888.
Schelbert HR. Positron emission tomography for the assessment of myocardial viability. Circulation 1991; 84 (Suppl):122–131.
Maes A, Flameng W, Nuyts J, et al. Histological alterations in chronically hypoperfused myocardium: correlation with PET findings. Circulation 1994; 90:735–745.
Schwaiger M, Hicks R. The clinical role of metabolic imaging of the heart by positron emission tomography. J Nucl Med 1991; 32:565–578.
Kloner RA, Ganote CE, Jennings RB. The ‘no reflow’ phenomenon after temporary coronary occlusion in the dog. J Clin Invest 1974; 54:1496–1508.
Willerson JT, Watson JT, Templeton GH, Fixler DE. Reduced myocardial reflow and increased coronary vascular resistance following prolonged myocardial ischemia in the dog. Circ Res 1975; 36:771–781.
Ito H, Tomooka T, Sakai N, Yu H, et al. Lack of myocardial perfusion immediately after successful thrombolysis. Circulation 1992; 85:1699–1705.
Maes A, Van de Werf F, Nuyts J, et al. Impaired myocardial tissue perfusion early after successful thrombolysis. Impact on myocardial flow, metabolism and function at late follow-up. Circulation 1995; 92:2072–2078.
Ragosta M, Camarano G, Kaul S, et al. Microvascular integrity indicates myocellular viability in patients with recent myocardial infarction: new insights using myocardial contrast echocardiography. Circulation 1994; 89:2562–2569.
Stewart R, Miller D, Bowers T, et al. PET perfusion and vasodilator function after angioplasty for acute myocardial infarction. J Nucl Med 1997; 38:770–777.
Neumann F, Kosa I, Dickfeld T, et al. Recovery of myocardial perfusion in acute myocardial infarction after successful balloon angioplasty and stent placement in the infarct-related coronary artery. J Am Coll Cardiol 1997; 30:1270–1276.
Czernin J, Porenta G, Brunken R, et al. Regional blood flow, oxidative metabolism and glucose utilization in patients with recent myocardial infarction. Circulation 1993; 88:884–895.
Maes A, Mortelmans L, Nuyts J, et al. Importance of flow/metabolism studies in predicting late recovery of function following reperfusion in patients with acute myocardial infarction. Eur Heart J 1997; 18:954–962.
Mesotten L, Maes A, Herregods M et al. PET ‘reversed mismatch pattern’ early after acute myocardial infarction: followup of flow, metabolism and function. Eur J Nucl Med 2001; 28:466–471.
Rauch BR, Helus F, Grunze M, Braunwall E, Hasselbach W, Kubler W. Kinetics of 13N-marker of myocardial blood flow. Circulation 1985; 71:387–393.
Camici P, Ferrannini E, Opie LH. Myocardial metabolism in ischemic heart disease: basic principles and application to imaging by positron emission tomography. Prog Cardiovasc Dis 1989; 32:217–238.
Hashimoto K, Uehara T, Ishida Y, et al. Paradoxical uptake of F-18 fluorodeoxyglucose by successfully reperfused myocardium during the sub-acute phase in patients with acute myocardial infarction. Ann Nucl Med 1996; 10:93–98.
Nishimura T, Uehara T, Ishida Y, et al. Is 18F-FDG a gold standard for myocardial viability? Assessment by sequential myocardial PET scan following acute myocardial infarction [abstract]. J Nucl Med 1993; 34:24P.
Jones HA, Sriskandan S, Peters AM, et al. Dissociation of neutrophil emigration and metabolic activity in lobar pneumonia and bronchiectasis. Eur Respir J 1997; 10:795–803.
Mesotten L, Dispersyn G, Maes A, et al. PET reversed mismatch in an experimental model of subacute myocardial infarction. Eur J Nucl Med 2001; 28:457–465.
Baldwin D, Mcfalls E, Jaimes D, et al. Myocardial glucose metabolism and ATP levels are decreased two days after global ischemia. J Surg Res 1996; 63:35–38.
Gropler RJ, Siegel B, Sampathkumaran K, et al. Dependence of recovery of contractile function on maintenance of oxidative metabolism after myocardial infarction. J Am Coll Cardiol 1992; 19:989–997.
Yamagishi H, Akioka K, Sakanoue Y, Takeuchi K, Yoshikawa J, Hironobu O. A reverse flow-metabolism mismatch pattern on PET is related to multivessel disease in patients with acute myocardial infarction. J Nucl Med 1999; 40:1492–1498.
Gropler R, Siegel B, Geltman E. Myocardial uptake of carbon- 11-acetate as an indirect estimate of regional myocardial blood flow. J Nucl Med 1991; 32:245–251.
Chan S, Brunken R, Phelps M, Schelbert H. Use of the metabolic tracer carbon-11-acetate for evaluation of regional myocardial perfusion. J Nucl Med 1991; 32:665–672.
Brown M, Myears D, Bergmann S. Validity of estimates of myocardial oxidative metabolism with carbon-11-acetate and positron emission tomography despite altered patterns of substrate utilisation. J Nucl Med 1989; 30:187–193.
Rubin P, Lee D, Davila-Roman V, et al. Superiority of C-11 acetate compared with F-18 fluorodeoxyglucose in predicting myocardial functional recovery by positron emission tomography in patients with acute myocardial infarction. Am J Cardiol 1996; 78:1230–1236.
Maes A, Van de Werf F, Mesotten L, et al. Early assessment of regional myocardial blood flow and metabolism in thrombolysis in myocardial infarction flow grade 3 reperfused myocardial infarction using carbon-11-acetate. J Am Coll Cardiol 2001; 37:30–36.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Mesotten, L., Maes, A., Van de Werf, F. et al. PET radiopharmaceuticals used in viability studies in acute myocardial infarction: a literature survey. Eur J Nucl Med 29, 3–6 (2002). https://doi.org/10.1007/s00259-001-0677-1
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00259-001-0677-1